| Males | Females | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
 | % (n/N) | PRb | 95% CI | PRc | 95% CI | % (n/N) | PRc | 95% CI | PRb | 95% CI |
Baseline | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Overweight/Obese | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Primary School | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Low PA School | 14 (51/371) | 1.0 | Ref | 1.0 | Ref | 12 (48/417) | 1.0 | Ref | 1.0 | Ref |
   Med PA School | 10 (48/460) | 0.76 | (0.52–1.11) | 0.80 | (0.57–1.12) | 13 (60/455) | 1.15 | (0.81–1.61) | 1.14 | (0.80–1.62) |
   High PA School | 11 (53/503) | 0.77 | (0.55–1.06) | 0.77 | (0.56–1.07) | 13 (59/472) | 1.09 | (0.80–1.48) | 1.10 | (0.83–1.47) |
p trend | Â | 0.13 | Â | 0.14 | Â | Â | 0.62 | Â | 0.51 | |
Secondary School | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Low PA School | 9 (40/440) | 1.0 | Ref | 1.0 | Ref | 12 (51/442) | 1.0 | Ref | 1.0 | Ref |
   Med PA School | 11 (55/485) | 1.25 | (0.78–1.99) | 1.27 | (0.86–1.88) | 13 (57/456) | 1.08 | (0.72–1.63) | 1.15 | (0.80–1.65) |
   High PA School | 11 (68/622) | 1.20 | (0.82–1.76) | 1.14 | (0.79–1.64) | 13 (69/532) | 1.12 | (0.80–1.59) | 1.15 | (0.81–1.64) |
p trend | Â | 0.39 | Â | 0.59 | Â | Â | 0.50 | Â | 0.44 | |
Follow-Up | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Overweight/Obese | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Low PA School | 59 (123/208) | 1.0 | Ref | 1.0 | Ref | 39 (92/239) | 1.0 | Ref | 1.0 | Ref |
   Med PA School | 66 (169/254) | 1.13 | (0.97–1.30) | 1.10 | (0.97–1.25) | 38 (96/250) | 1.00 | (0.78–1.28) | 0.98 | (0.79–1.22) |
   High PA School | 63 (182/288) | 1.07 | (0.93–1.23) | 1.08 | (0.95–1.23) | 41 (110/270) | 1.06 | (0.83–1.34) | 1.04 | (0.84–1.28) |
p trend | Â | 0.46 | Â | 0.33 | Â | Â | 0.63 | Â | 0.63 |